Variant report
Variant | esv2763451 |
---|---|
Chromosome Location | chr5:44571144-44576171 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577604250 | chr5:44574605-44574606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543438676 | chr5:44574612-44574613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs563603605 | chr5:44574656-44574657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555366031 | chr5:44574679-44574680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374458842 | chr5:44574694-44574695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573943038 | chr5:44574735-44574736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs11954650 | chr5:44574743-44574744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541442702 | chr5:44574758-44574759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375060498 | chr5:44574798-44574799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549264458 | chr5:44574815-44574816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs151163004 | chr5:44574828-44574829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11954674 | chr5:44574831-44574832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11954676 | chr5:44574838-44574839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555532468 | chr5:44574861-44574862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140335755 | chr5:44574864-44574865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183642650 | chr5:44574886-44574887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11958780 | chr5:44574957-44574958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs146988535 | chr5:44574958-44574959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs72750292 | chr5:44574965-44574966 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs4642379 | chr5:44574988-44574989 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs567655427 | chr5:44574997-44574998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536566730 | chr5:44575014-44575015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371848814 | chr5:44575015-44575016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189260786 | chr5:44575019-44575020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192792270 | chr5:44575064-44575065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184848933 | chr5:44575069-44575070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs376970554 | chr5:44575107-44575108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577790103 | chr5:44575155-44575156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77539885 | chr5:44575177-44575178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549689455 | chr5:44575191-44575192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567627526 | chr5:44575192-44575193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543478357 | chr5:44575216-44575217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563288401 | chr5:44575223-44575224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34577718 | chr5:44575226-44575227 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs74415715 | chr5:44575234-44575235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142279052 | chr5:44575391-44575392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528317560 | chr5:44575394-44575395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577854301 | chr5:44575418-44575419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565321346 | chr5:44575456-44575457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs146071923 | chr5:44575457-44575458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138747792 | chr5:44575481-44575482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376331430 | chr5:44575512-44575513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111613133 | chr5:44575555-44575556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563322199 | chr5:44575572-44575573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73093953 | chr5:44575584-44575585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539548123 | chr5:44575585-44575586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567322442 | chr5:44575591-44575592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs529993754 | chr5:44575611-44575612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547016873 | chr5:44575648-44575649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74776155 | chr5:44575649-44575650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:44574600-44575200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr5:44574600-44575400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:44574800-44575200 | Enhancers | Hela-S3 | cervix |
4 | chr5:44574800-44575400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr5:44575000-44575400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr5:44575200-44579200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |